However, compared with the AD group, PhM and concurrent administration of MH or ZC with AlCl3 dramatically reduced ACSL4 signaling by downregulating ACSL4 mRNA expressions by 32%, 56%, and 59%, respectively. Here, ACSL4 is linked to Alzheimer disease.